US2006240083A1PendingUtilityA1
Antimicrobial and immunostimulating composition
Est. expiryMar 30, 2020(expired)· nominal 20-yr term from priority
A61K 33/38A61L 2300/104A61K 31/716A61L 2300/426A61L 2300/232A61L 2300/45Y02A50/30A61L 31/16A61L 15/44A61L 2300/404A61L 15/46
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A medical composition comprising an antimicrobially effective and immunostimulating amount of a combination of a β-glucan component and a silver-containing component is disclosed. The medical composition may be adapted for use topically or incorporated with a mesh material which may be further adapted for use as a wound dressing or as a surgical mesh. Methods for manufacturing the medical compositions described herein are also provided. The invention further provides methods for treating tissue damaged by wound or burn, and methods for treating or repairing tissue at a surgical site.
Claims
exact text as granted — not AI-modified1 . A wound dressing comprising:
(a) a mesh material; and (b) a composition comprising an antimicrobially effective and immunostimulating amount of a combination of a β-glucan component and a silver-containingcomponent.
2 . The wound dressing of claim 1 , wherein the wound dressing includes a first layer comprising the mesh material, and a second layer comprising the composition.
3 . The wound dressing of claim 1 , wherein the mesh material comprises a synthetic material.
4 . The wound dressing of claim 1 , wherein the mesh material comprises a synthetic material selected from the group consisting of polyester, polypropylene, polytetrafluoroethylene, expanded polytetrafluoroethylene, polyurethane, polyethylene terephthalate, polyglycolic acid, polyglactin, and silicone.
5 . The wound dressing of claim 1 , wherein the mesh material comprises a material derived from a human source, an animal source, or a cadaveric source.
6 . The wound dressing of claim 1 , wherein the mesh material is impregnated with the composition.
7 . The wound dressing of claim 1 , wherein the composition is coated onto the mesh material.
8 . The wound dressing of claim 1 , wherein about 0.01% to about 50% by weight of the wound dressing is the β-glucan component, and about 0.01% to about 15% by weight of the wound dressing is the silver-containing component.
9 . The wound dressing of claim 1 , wherein the composition includes about 10 parts by weight of cereal-derived β-glucan to about 3 parts by weight silver nitrate.
10 . The wound dressing of claim 1 , wherein the composition further comprises collagenic protein.
11 . The wound dressing of claim 1 , wherein about 0.1% to about 20% by weight of the wound dressing is the collagenic protein.
12 . The wound dressing of claim 1 , and further comprising, as an exterior surface, a polymeric vapor-permeable film in contact with the mesh material.
13 . The wound dressing of claim 1 , wherein the P-glucan component is a cereal-derived β-glucan compound.
14 . The wound dressing of claim 13 , wherein the β-glucan compound is derived from wheat, oats, barley, or a combination thereof.
15 . The wound dressing of claim 13 , wherein the β-glucan compound has a molecular weight in the range of about 1 kDa to about 1500 kDa.
16 . The wound dressing of claim 13 , wherein the β-glucan compound has a molecular weight in the range of about 200 kDa to about 700 kDa.
17 . The wound dressing of claim 13 , wherein the β-glucan compound includes (1-3)(1-4) β-D-glucan.
18 . A method for treating tissue damaged by wound or burn, comprising the steps of:
a) cleaning a site of damaged tissue; and b) applying topically to the site an antimicrobial and immunostimulating composition comprising a combination of a β-glucan component and a silver-containing component.
19 . The method of claim 18 , and including repeating application of the composition intermittently until healing of the damaged tissue is complete.
20 . A method for treating tissue damaged by wound or burn, comprising the steps of:
a) cleaning a site of damaged tissue; and b) covering the site with a wound dressing comprising a mesh material; and c) a composition comprising an antimicrobially effective and immunostimulating amount of a combination of a β-glucan component and a silver-containing component.
21 . A method for treating or repairing tissue at a surgical site comprising the step of applying to the surgical site a biocompatible mesh device, the mesh device comprising:
a) a mesh matrix; and b) a composition comprising an antimicrobially effective and immunostimulating amount of a combination of a β-glucan component and a silver-containing component.Join the waitlist — get patent alerts
Track US2006240083A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.